Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Microbiome

Jose U. Scher, MD, Steven B. Abramson, MD  |  Issue: November 2011  |  November 1, 2011

Struggling to convince the Royal Society, van Leeuwenhoek observed the plaque between his own teeth “with great wonder, that in the said matter there were many very little living animalcules, very prettily a-moving.”

It would take two centuries, however, to prove these animalcules responsible for the origin of infectious processes. With Koch and Pasteur leading and rationalizing the nascent field of microbiology, most medical disciplines then turned into an “infectious rush era.” The logic followed that, since bacteria caused all cardinal signs of inflammation in affected sites, rheumatic diseases were also inevitably a deleterious effect of microorganisms. Theories flourished, and multiple lines of investigation suggested a link between oral or intestinal microbes and RA. Soon after, arthritis deformans was considered to be due to tuberculosis; the focal sepsis hypothesis claimed that RA was caused by periodontal flora; and the toxemic factor idea proposed a role in diseases of substances produced by intestinal bugs.1,7-9 The first half of the 20th century, without the means to prove any of these hypotheses (mainly because one in five bacteria are noncultivable), saw thousands of teeth extractions and even dozens of colectomies performed, hoping to achieve the ultimate cure for RA. Ultimately, none of those expectations materialized, and surgical solutions for RA were gradually abandoned.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Most recently (although debated), paleopathological and epidemiologic evidence has suggested that RA originated in the New World and spread through a transmissible vector to the rest of the globe after 1492.10 These conclusions are based on the lack of skeletal remains with RA-like features outside of America and the high incidence of disease in Amerindians compared with Caucasians, Europeans, Africans, and Asians. Clinical studies implicating specific bacterial agents as triggers for RA have mostly relied on indirect evidence (serological and biased polymerase chain reaction methods) and circumstantial observations.

Who Needs Culture, Anyway?

What theoretically appeared reasonable and necessary to advance the understanding of the microbiome has, nevertheless, encountered challenges. Central to these challenges is the inability to culture and grow approximately 80% of bacteria found in our microbiomes. Whether related to oxygen conditions or nutritional requirements, the immense majority of bacteria cannot survive if they leave their natural habitats. Because this deportation means death for many species, the DNA sequencing technology revolution has enabled the unimaginable: to bypass the need to isolate living organisms for their identification (see Figure 2).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Figure 2

Figure 2
click for large version

Culture-independent genomic analysis of the human microbiome. Culture-independent techniques have advanced our capacity to survey complex microbial communities in human samples. Well-characterized individuals (healthy and diseased) are asked to donate samples for microbiome analyses. Two metagenomic sequencing approaches are utilized. Conserved and variable 16S rRNA genomic regions are amplified and subjected to pyrosequencing. The resulting sequences are then aligned, filtered, and compared with publicly available databases of 16S rRNA sequences, enabling taxonomic classification of bacteria present or absent in a given sample. Whole genome shotgun sequencing provides information that enables identification of genes present and allows for subsequent comparison of enzymatic pathways and functions represented among different samples. Enzymatic databases are also available to assist in the identification of protein function, enabling the richness and diversity of functional capacities provided by the microbiome to be assessed.

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:bacteriaMicrobiomePathogenesisRAResearchRheumatoid arthritis

Related Articles
    The Microbiome in Pediatric Rheumatic Diseases

    The Microbiome in Pediatric Rheumatic Diseases

    April 15, 2016

    The human intestinal microbiota is home to more than 1,000 bacterial species, containing approximately 3 million genes, many of which code for functions that have the potential to affect human physiology.1 Smaller numbers of organisms are also present in the skin, upper gastrointestinal tract, female reproductive tract and the oro- and nasopharynx. As tools have…

    Research Provides Insight into Impact of Microbiome on Health, Rheumatic Disease

    April 15, 2016

    The microbiome comprises diverse microbial flora, including bacteria, viruses and fungi, that live on mucosal surfaces, predominantly the skin and digestive tract. Microbes evolved billions of years prior to the development of modern Homo sapiens 200,000 years ago; we have always existed with their ubiquitous presence. Despite this, the first microbe was not visualized until…

    Research Suggests Th17 Cells Have Microbiota-Dependent Role in RA

    March 18, 2019

    A growing body of research is elucidating the role of intestinal microbiota in several auto­immune diseases, including rheumatoid arthritis (RA). Research published in December 2018 Arthritis & Rheumatology increases our understanding of the “extent and nature of mucosal immune activation during preclinical arthritis.”1 The research objective, according to the report, was to “dissect intestinal mucosal immune…

    Anatomy Insider / shutterstock.com

    Gut Instinct: Ankylosing Spondylitis & the Microbiome

    October 3, 2019

    CHICAGO—At the 2019 ACR State-of-the-Art Clinical Symposium, an annual gathering featuring talks by key opinion leaders on the most salient topics for practicing rheumatologists and healthcare providers, Jose U. Scher, MD, director of the Microbiome Center for Rheumatology and Autoimmunity at NYU Langone Medical Center, New York City, was the featured speaker. In his remarks,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences